IER2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.93343999999041E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.615000E-04 |
Normal-vs-Stage2 |
2.37410000003546E-06 |
Normal-vs-Stage3 |
8.69009999959758E-07 |
Normal-vs-Stage4 |
5.66149999992049E-07 |
Stage1-vs-Stage2 |
4.141300E-03 |
Stage1-vs-Stage3 |
5.5731999999975E-05 |
Stage1-vs-Stage4 |
3.59280000000739E-05 |
Stage2-vs-Stage3 |
6.853400E-01 |
Stage2-vs-Stage4 |
4.686000E-01 |
Stage3-vs-Stage4 |
6.827600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.03460000000044E-05 |
Normal-vs-AfricanAmerican |
1.010980E-04 |
Normal-vs-Asian |
5.59900000030034E-07 |
Caucasian-vs-AfricanAmerican |
8.237200E-01 |
Caucasian-vs-Asian |
3.065700E-02 |
AfricanAmerican-vs-Asian |
6.202200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.65300000001911E-06 |
Normal-vs-Female |
2.550500E-04 |
Male-vs-Female |
5.398000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.21410000000155E-05 |
Normal-vs-Age(41-60Yrs) |
2.06019999999807E-05 |
Normal-vs-Age(61-80Yrs) |
2.13999999999492E-05 |
Normal-vs-Age(81-100Yrs) |
7.558600E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.529000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.518400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.182800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.873000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.307600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.344200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.581800E-01 |
Normal-vs-Grade 2 |
1.575030E-04 |
Normal-vs-Grade 3 |
3.86200000002113E-06 |
Normal-vs-Grade 4 |
1.81250000008681E-07 |
Grade 1-vs-Grade 2 |
3.613400E-01 |
Grade 1-vs-Grade 3 |
1.953770E-01 |
Grade 1-vs-Grade 4 |
1.003840E-01 |
Grade 2-vs-Grade 3 |
1.156430E-02 |
Grade 2-vs-Grade 4 |
6.14840000023875E-07 |
Grade 3-vs-Grade 4 |
9.898000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.95769999999618E-05 |
Normal-vs-ccB subtype |
1.15749999995973E-06 |
ccA subtype-vs-ccB subtype |
4.197800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.4750999999833E-06 |
Normal-vs-N1 |
1.16199999622424E-08 |
N0-vs-N1 |
7.62690000000177E-05 |
|
|